Weapons of penile smooth muscle destruction: Androgen deficiency promotes accumulation of adipocytes in the corpus cavernosum

References

• Karadeniz T, Topsakal M, Aydogmus A, Gulgun C, Aytekin Y, Basak D. Correlation of ultrastructural alterations in cavernous tissue with the clinical diagnosis vasculogenic impotence. Urol Int 1996; 57: 58–61
   PubMed Web of Science ®Google Scholar
• Mersdorf A, Goldsmith P C, Diederichs W, Padula C A, Lue T F, Fishman I J, Tanagho E A. Ultrastructural changes in impotent penile tissue: a comparison of 65 patients. J Urol 1991; 145: 749–758
   PubMed Web of Science ®Google Scholar
• Ellis W J, Grayhack J T. Sexual function in aging males after orchiectomy and estrogen therapy. J Urol 1963; 89: 895–898
   Web of Science ®Google Scholar
• Peters C A, Walsh P C. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med 1987; 317: 599–604
   PubMed Web of Science ®Google Scholar
• Rousseau L, Dupont A, Labrie F, Couture M. Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration. Arch Sex Behav 1988; 17: 87–98
   PubMed Web of Science ®Google Scholar
• Marumo K, Baba S, Murai M. Erectile function and nocturnal penile tumescence in patients with prostate cancer undergoing luteinizing hormone-releasing hormone agonist therapy. Int J Urol 1999; 6: 19–23
   PubMed Web of Science ®Google Scholar
• Greenstein A, Plymate S R, Katz P G. Visually stimulated erection in castrated men. J Urol 1995; 153: 650–652
   PubMed Web of Science ®Google Scholar
• Hirshkowitz M, Moore C A, O'Connor S, Bellamy M, Cunningham G R. Androgen and sleep-related erections. J Psychosom Res 1997; 42: 541–546
   PubMed Web of Science ®Google Scholar
• Eri L M, Tveter K J. Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in treatment of benign prostatic hyperplasia. J Urol 1994a; 152: 448–452
   PubMed Web of Science ®Google Scholar
• Eri L M, Tveter K J. Safety, side effects and patient acceptance of the antiandrogen Casodex in the treatment of benign prostatic hyperplasia. Eur Urol 1994b; 26: 219–226
   PubMed Web of Science ®Google Scholar
• Aversa A, Isidori A M, De Martino M U, Caprio M, Fabbrini E, Rocchietti-March M, Frajese G, Fabbri A. Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol 2000; 53: 517–522
   PubMed Web of Science ®Google Scholar
• Aversa A, Isidori A M, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol 2003; 58: 632–638
   PubMed Web of Science ®Google Scholar
• Aversa A, Isidori A M, Greco E A, Giannetta E, Gianfrilli D, Spera E, Fabbri A. Hormonal supplementation and erectile dysfunction. Eur Urol 2004; 45: 535–538
   PubMed Web of Science ®Google Scholar
• Shabsigh R, Kaufman J M, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004; 172: 658–663
   PubMed Web of Science ®Google Scholar
• Seftel A D, Mack R J, Secrest A R, Smith T M. Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning. J Androl 2004; 25: 963–972
   PubMedGoogle Scholar
• Foresta C, Caretta N, Rossato M, Garolla A, Ferlin A. Role of androgens in erectile function. J Urol 2004; 171: 2358–2362
   PubMed Web of Science ®Google Scholar
• Gray P B, Singh A B, Woodhouse L J, Storer T W, Casaburi R, Dzekov J, Dzekov C, Sinha-Hikim I, Bhasin S. Dose-dependent effects of testosterone on sexual function, mood and visuospatial cognition in older men. J Clin Endocrinol Metab 2005; 90: 3838–3846
   PubMed Web of Science ®Google Scholar
• Mills T M, Lewis R W, Stopper V S. Androgenic maintenance of inflow and veno-occlusion during erection in the rat. Biol Reprod 1998; 59: 1413–1418
   PubMed Web of Science ®Google Scholar
• Mills T M, Stopper V S, Reilly C M. Sites of androgenic regulation of cavernosal blood pressure during penile erection in the rat. Int J Impot Res 1996; 8: 29–34
   PubMedGoogle Scholar
• Mills T M, Stopper V S, Wiedmeier V T. Effects of castration and androgen replacement on the hemodynamics of penile erection in the rat. Biol Reprod 1994; 51: 234–238
   PubMed Web of Science ®Google Scholar
• Mills T M, Wiedmeier V T, Stopper V S. Androgen maintenance of erectile function in the rat penis. Biol Reprod 1992; 46: 342–348
   PubMed Web of Science ®Google Scholar
• Baba K, Yajima M, Carrier S, Morgan D M, Nunes L, Lue T F, Iwamoto T. Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis. BJU Int 2000; 85: 953–958
   PubMed Web of Science ®Google Scholar
• Baba K, Yajima M, Carrier S, Akkus E, Reman J, Nunes L, Lue T F, Iwamoto T. Effect of testosterone on the number of NADPH diaphorase-stained nerve fibers in the rat corpus cavernosum and dorsal nerve. Urology 2000; 56: 533–538
   PubMed Web of Science ®Google Scholar
• Nanasaki Y, Sakuma Y. Perineal musculature and its innervation by spinal motoneurons in the male rabbit: effects of testosterone. J Nippon Med Sch 2000; 67: 164–171
   PubMedGoogle Scholar
• Matsumoto A. Androgen stimulates neuronal plasticity in the perineal motoneurons of aged male rats. J Comp Neurol 2001; 430: 389–395
   PubMed Web of Science ®Google Scholar
• Rand M N, Breedlove S M. Androgen alters the dendritic arbors of SNB motoneurons by acting upon their target muscles. J Neurosci 1995; 15: 4408–4416
   PubMed Web of Science ®Google Scholar
• Yue P, Chatterjee K, Beale C, Poole-Wilson P A, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 1995; 91: 1154–1160
   PubMed Web of Science ®Google Scholar
• Deenadayalu V P, White R E, Stallone J N, Gao X, Garcia A J. Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium-channel. Am J Physiol 2001; 281: H1720–H1727
   PubMed Web of Science ®Google Scholar
• Scragg J L, Jones R D, Channer K S, Jones T H, Peers C. Testosterone is a potent inhibitor of L-type Ca2+ channels. Biochem Biophys Res Comm 2004; 318: 503–506
   PubMed Web of Science ®Google Scholar
• Traish A M, Park K, Dhir V, Kim N N, Moreland R B, Goldstein I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 1999; 140: 1861–1868
   PubMed Web of Science ®Google Scholar
• Traish A M, Munarriz R, O'Connell L, Choi S, Kim S W, Kim N N, Huang Y H, Goldstein I. Effects of medical and surgical castration on erectile function in an animal model. J Androl 2003; 24: 381–387
   PubMed Web of Science ®Google Scholar
• Luangkhot R, Rutchik S, Agarwal V, Puglia K, Bhargava G, Melman A. Collagen alterations in the corpus cavernosum of men with sexual dysfunction. J Urol 1992; 148: 467–471
   PubMed Web of Science ®Google Scholar
• Persson C, Diederichs W, Lue T F, Yen T SB, Fishman I J, Mclin P, Tanagho E A. Correlation of altered penile ultrastructure with clinical arterial evaluation. J Urol 1989; 142: 1462–1468
   PubMed Web of Science ®Google Scholar
• Mersdorf A, Goldsmith P C, Diederichs W, Padula C A, Lue T F, Fishman I J, Tanagho E A. Ultrastructural changes in impotent penile tissue: a comparison of 65 patients. J Urol 1991; 145: 749–758
   PubMed Web of Science ®Google Scholar
• Wespes E, Goes P M, Schiffmann S, Deprierreux M, Vanderhaeghen J J, Schulman C C. Computerized analysis of smooth muscle fibers in potent and impotent patients. J Urol 1991; 146: 1015–1017
   PubMed Web of Science ®Google Scholar
• Jevtich M, Khawand N Y, Vidic B. Clinical significance of ultrastructural findings in the corpus cavernosa of normal and impotent men. J Urol 1990; 143: 289–293
   PubMed Web of Science ®Google Scholar
• Nehra A, Goldstein I, Pabby A, Nugent M, Huang Y H, de las Morenas A, Krane R J, Udelson D, Saenz de Tejada I, Moreland R B. Mechanisms of venous leakage: a prospective clinicopathological correlation of corporeal function and structure. J Urol 1996; 156: 1320–1329
   PubMed Web of Science ®Google Scholar
• Wespes E, Schiffmann S, Depierreux M, Vanderhaegan J J, Schulman C C. Is cavernovenous leakage related to a reduction of intracavernous smooth muscle fibers. Int J Impot Res 1990; 2: 30
   Google Scholar
• Rogers R S, Graziottin T M, Lin C M, Kan Y W, Lue T. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003; 15: 26–37
   PubMed Web of Science ®Google Scholar
• Traish A M, Kim N N. The physiological role of androgens in penile erection: regulation of corpus cavernosum structure and function. J Sex Med 2005; 2: 759–770
   PubMed Web of Science ®Google Scholar
• Kimura K, Markowski M, Bowen C, Gelmann E P. Androgen blocks apoptosis of hormone-dependent prostate cancer cells. Cancer Res 2001; 61: 5611–5618
   PubMed Web of Science ®Google Scholar
• Sun M, Yang L, Feldman R I, Sun X M, Bhalla K N, Jove R, Nicosia S V, Cheng J Q. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. J Biol Chem 2003; 278: 42992–43000
   PubMed Web of Science ®Google Scholar
• Traish A M, Toselli P, Jeong S J, Kim N N. Adipocyte accumulation in penile corpus cavernosum of the orchiectomized rabbit: a potential mechanism for veno-occlusive dysfunction in androgen deficiency. J Androl 2005; 26: 242–248
   PubMed Web of Science ®Google Scholar
• Moon D G, Sung D J, Kim Y S, Cheon J, Kim J J. Bisphenol A inhibits penile erection via alteration of histology in the rabbit. Int J Impot Res 2001; 13: 309–316
   PubMed Web of Science ®Google Scholar
• Moon D G, Lee K C, Kim Y W, Park H S, Cho H Y, Kim J J. Effect of TCDD on corpus cavernosum histology and smooth muscle physiology. Int J Impot Res 2004; 16: 224–230
   PubMed Web of Science ®Google Scholar
• Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 2005; 84: 319–327
   PubMed Web of Science ®Google Scholar
• Goyal H O, Braden T D, Williams C S, Dalvi P, Williams J W, Srivastava K K. Exposure of neonatal male rats to estrogen induces abnormal morphology of the penis and loss of fertility. Reprod Toxicol 2004; 18: 265–274
   PubMed Web of Science ®Google Scholar
• Goyal H O, Braden T D, Williams C S, Dalvi P, Mansour M M, Mansour M, Williams J W, Bartol F F, Wiley A A, Birch L, Prins G S. Abnormal morphology of the penis in male rats exposed neonatally to diethylstilbestrol is associated with altered profile of estrogen receptor-alpha protein, but not of androgen receptor protein: a developmental and immunocytochemical study. Biol Reprod 2004; 70: 1504–1517
   PubMed Web of Science ®Google Scholar
• Goyal H O, Braden T D, Williams C S, Dalvi P, Mansour M M, Williams J W. Permanent induction of morphological abnormalities in the penis and penile skeletal muscles in adult rats treated neonatally with diethylstilbestrol or estradiol valerate: a dose-response study. J Androl 2005; 26(1)32–43
   PubMedGoogle Scholar
• Goyal H O, Braden T D, Williams C S, Dalvi P, Mansour M, Williams J W. Estrogen-induced abnormal accumulation of fat cells in the rat penis and associated loss of fertility depends upon estrogen exposure during critical period of penile development. Toxicol Sci 2005; 87(1)242–254
   PubMed Web of Science ®Google Scholar
• Bhasin S, Taylor W E, Singh R, Artaza J, Sinha-Hikim I, Jasuja R, Choi H, Gonzalez-Cadavid N F. The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action. J Gerontol 2003; 58A: 1103–1110
   Google Scholar
• Singh R, Artaza J N, Taylor W E, Gonzalez-Cadavid N F, Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 2003; 144: 5081–5088
   PubMed Web of Science ®Google Scholar
• Anderson L A, McTernan P G, Harte A L, Barnett A H, Kumar S. The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes Obes Metab 2002; 4(3)209–213
   PubMed Web of Science ®Google Scholar
• Corradi L S, Goes R M, Carvalho H F, Taboga S R. Inhibition of 5α-reductase activity induces stromal remodeling and smooth muscle de-differentiation in adult gerbil ventral prostate. Differentiation 2004; 72: 198–208
   PubMed Web of Science ®Google Scholar
• Rucker-Martin C, Pecker F, Godreau D, Hatem S N. Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro. Cardiovasc Res 2002; 55: 38–52
   PubMed Web of Science ®Google Scholar
• Johnson J L, van Eys G J, Angelini G D, George S J. Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein. Arterioscler Thromb Vasc Biol 2001; 21: 1146–1151
   PubMed Web of Science ®Google Scholar
• Hausman G J. Dexamethasone induced preadipocyte recruitment and expression of CCAAT/enhancing binding protein alpha and peroxisome proliferator activated receptor-gamma proteins in porcine stromal-vascular (S-V) cell cultures obtained before and after the onset of fetal adipogenesis. Gen Comp Endocrinol 2003; 133: 61–70
   PubMed Web of Science ®Google Scholar
• Rosen E D. Molecular mechanisms of adipocyte differentiation. Ann Endocrinol (Paris) 2002; 63: 79–82
   PubMed Web of Science ®Google Scholar
• Rosen E D, Hsu C, Wang X, Sakai S, Freeman M W, Gonzalez F J, Spiegelman B M. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 2002; 16: 22–26
   PubMed Web of Science ®Google Scholar
• Rosen E D, Spiegelman B M. Molecular regulation of adipogenesis. Ann Rev Cell Dev Biol 2000; 16: 145–171
   PubMed Web of Science ®Google Scholar
• Wright H M, Clish C B, Mikami T, Hauser S, Yanagi K, Hiramatsu R, Serhan C N, Spiegelman B M. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J Biol Chem 2000; 275: 1873–1877
   PubMed Web of Science ®Google Scholar
• Dieudonne M N, Pecquery R, Boumediene A, Leneveu M C, Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 1998; 274: C1645–1652
   PubMed Web of Science ®Google Scholar
• Garcia E, Lacasa M, Agli B, Giudicelli Y, Lacasa D. Modulation of rat preadipocyte adipose conversion by androgenic status: involvement of C/EBPs transcription factors. J Endocrinol 1999; 161: 89–97
   PubMed Web of Science ®Google Scholar
• Belanger C, Luu-The V, Dupont P, Tchernof A. Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm Metab Res 2002; 34: 737–745
   PubMed Web of Science ®Google Scholar
• Wong Y C, Tam N N. Dedifferentiation of stromal smooth muscle as a factor in prostate carcinogenesis. Differentiation 2002; 70: 633–645
   PubMed Web of Science ®Google Scholar
• Chen W, Yang C C, Sheu H M, Seltmann H, Zouboulis C C. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 2003; 121: 441–447
   PubMed Web of Science ®Google Scholar
• Bostrom K, Tintut Y, Kao S C, Stanford W P, Demer L L. HOXB7 overexpression promotes differentiation of C3H10T1/2 cells to smooth muscle cells. J Cell Biochem 2000; 78: 210–221
   PubMed Web of Science ®Google Scholar
• Hu E, Tontonoz P, Spiegelman B M. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 1995; 92: 9856–9860
   PubMed Web of Science ®Google Scholar